Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Generics [UK] Limited t/a Mylan, Station Close, Potters Bar, Hertfordshire, EN6 1TL
Eprosartan Mylan 300 mg Film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. 300 mg: A white to off-white, film coated, oval, biconvex, bevelled edge tablet imprinted with ‘M EN1’ in black ink on one side of the tablet and blank on the other side. |
Each film-coated tablet contains 367.90 mg of eprosartan mesilate equivalent to 300 mg of eprosartan.
Excipient with known effect: 21.390 mg of lactose monohydrate per 300 mg tablet.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Eprosartan |
Eprosartan is a potent, synthetic, orally active non-biphenyl non-tetrazole angiotensin II receptor antagonist, which binds selectively to the AT1 receptor. |
| List of Excipients |
|---|
|
Tablet core: Lactose monohydrate Film coating: Hydroxypropyl cellulose (E462) Imprinting ink: Shellac |
White HDPE bottle with a white opaque polypropylene screw cap with induction sealing liner. Pack size of 500 film-coated tablets
Aluminium foil blisters laminated with PVC on one side and coated with a heat seal lacquer (Aclar/PVC/Al). Pack sizes of 14, 28, 30, 56, 98, 100 or 168 film-coated tablets. Calendar pack sizes of 14, 28, 56, 98 and 168 film-coated tablets.
Not all pack sizes may be marketed.
Generics [UK] Limited t/a Mylan, Station Close, Potters Bar, Hertfordshire, EN6 1TL
PL 04569/1227
14/03/2012
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
